CTMX Stock Summary and Trading Ideas (Cytomx Therapeutics | NASDAQ:CTMX)

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Cytomx Therapeutics trades on the NASDAQ stock market under the symbol CTMX.

As of September 11, 2026, CTMX stock price declined to $3.29 with 2,111,285 million shares trading.

CTMX has a beta of 0.98, meaning it tends to be less sensitive to market movements. CTMX has a correlation of 0.03 to the broad based SPY ETF.

CTMX has a market cap of $716.24 million. This is considered a Small Cap stock.

Last quarter Cytomx Therapeutics reported $1 million in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-10 million and exceeded earnings estimates by $.01.

In the last 3 years, CTMX traded as high as $8.21 and as low as $.40.

The top ETF exchange traded funds that CTMX belongs to (by Net Assets): XBI, VTI, VXF, VTWO, VHT.

CTMX has outperformed the market in the last year with a return of +58.9%, while the SPY ETF gained +18.3%. In the last 3 month period, CTMX beat the market returning +13.1%, while SPY returned +5.6%. However, in the most recent 2 weeks CTMX has underperformed the stock market by returning -3.8%, while SPY returned -0.9%.

CTMX support price is $3.21 and resistance is $3.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTMX shares will trade within this expected range on the day.